Vyvanse Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

VYVANSE capsules contain 20 mg, 30 mg and 50 mg of lisdexamfetamine dimesylate (equivalent to 11.6 mg, 17.3 mg and 28.9 mg of lisdexamfetamine).
VYVANSE (lisdexamfetamine dimesylate), a CNS stimulant, is for once-a-day oral administration. The chemical designation for lisdexamfetamine dimesylate is (2S)-2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl] hexanamide dimethanesulfonate. The molecular formula is C₁₅H₂₅N₃O·(CH₄O₃S)₂, which corresponds to a molecular weight of 455.60.
Lisdexamfetamine dimesylate is a white to off-white powder that is soluble in water (792 mg/mL).
Excipients/Inactive Ingredients: microcrystalline cellulose, croscarmellose sodium, and magnesium stearate. The capsule shells contain gelatin, titanium dioxide, and one or more of the following: FD&C Red #3, FD&C Blue #1, Black Iron Oxide, and Yellow Iron Oxide.
Excipients of Human or Animal Origin: The capsule shells of VYVANSE contain gelatin derived from bovine and/or porcine origins.

lisdexamfetamine

Manufacturer:

Takeda

Distributor:

Zuellig